Clinical Journal of the American Society of Nephrology

Plasma Levels of Growth Differentiation Factor-15 and Adverse Kidney Outcomes: Proteomics-Based Mediation Analysis and Mendelian Randomization

Cohort study of 31,965 peopleBiomarkers

Dose-response

The paper